Surface Ophthalmics, Inc.

Quick facts

Phase 2 pipeline

• Betamethasone Sodium Phosphate 0.01% · Ophthalmology
  Betamethasone sodium phosphate is a corticosteroid that reduces inflammation and suppresses the immune system.
• Mycophenolic Acid 0.1%
• Mycophenolic Acid 0.3%
• SURF-201

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Surface Ophthalmics, Inc. portfolio CI brief
• Surface Ophthalmics, Inc. pipeline updates RSS